Icritical Care: All Audio

Cystic fibrosis patient care has advanced greatly in recent years and the mortality rate has improved.

Continuous monitoring on hospital wards can prevent adverse events and unnecessary ICU admissions.

COVID-19 is associated with a high prevalence of coagulopathy and venous thromboembolism.

Procalcitonin testing on admission seems to be a valuable piece of information for early risk assessment and ruling out bacterial co-infection in COVID-19 patients.

The increase in acute kidney injury in COVID-19 patients is resulting in more utilization of renal replacement therapy (RRT) and continuous renal replacement therapy (CRRT).

Alternative strategies are needed to combat and prevent antibiotic-resistant bacterial infections. Host Ashish K. Khanna, MD, FCCP, FCCM, talks with David R. Cameron, PhD, about the potential for bacteriophage prophylaxis in the context of experimental ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.

Review how to best utilize parameters provided by minimally invasive advanced hemodynamic monitors. Host Michael Smith, MD, talks with Michael Scott, MBChB, about clinical thresholds that may warrant continuous advanced hemodynamic monitoring and the application of parameters such as stroke volume and stroke volume variation when administering fluid.

Montefiore Medical Center in the Bronx, New York, USA, quickly converted a children's hospital to an adult COVID-19 hospital.

Clinicians are working to understand and formulate an effective treatment for COVID-19-associated acute respiratory distress syndrome.

In a situation where ventilators are in short supply, multiple patients on a single ventilator could be a strategy of last resort.

The National Institutes of Health has released Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.

Discovery, the Critical Care Research Network's Viral Infection and Respiratory Illness Universal Study creates a real-time COVID-19 registry of current ICU and hospital care patterns.

Explore the need for randomized COVID-19 clinical trials and the difficulties and potential consequences of misinformation with host Ashish K. Khanna, MD, FCCP, FCCM, and Nicholas E. Ingraham, MD.

Gain valuable insight on the clinical management of COVID-19 and its relevance to the pediatric critical care provider with host Elizabeth H. Mack, MD, MS, FCCM, and Jacqueline Ong, MB BChir, MMed (Paeds), MRCPCH

Margaret M. Parker, MD, MCCM, and Christopher S. Parshuram, MBChB, PhD, discuss clinician moral distress in Canadian pediatric and neonatal intensive care units.

Review neurologic manifestations of COVID-19 and other severe respiratory viral contagions with host Ludwig H. Lin, MD, and author Christopher P.

Explore the Surviving Sepsis Campaign Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)

Kyle B. Enfield, MD, and Craig M. Lilly, MD, discuss the newly released guidance for vaping-associated respiratory distress syndrome, published in Critical Care Explorations.

Margaret M. Parker, MD, MCCM, and Jerry J. Zimmerman, MD, PhD, FCCM talk about the trajectory of long-term mortality and significant health-related quality of life disability among children encountering septic shock.

Margaret M. Parker, MD, MCCM, and Scott L. Weiss, MD, FCCM, discuss the release of: Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children